Shai Meretzki - Bonus Biogroup CEO and Presidentident, Director
| BONS Stock | ILS 16.60 0.30 1.78% |
CEO
Shai Meretzki is CEO and Presidentident, Director of Bonus Biogroup since 2012.
| Age | 54 |
| Tenure | 12 years |
| Phone | 972 7 320 67104 |
| Web | https://www.bonusbiogroup.com |
Bonus Biogroup Management Efficiency
The company has return on total asset (ROA) of (0.0636) % which means that it has lost $0.0636 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5522) %, meaning that it generated substantial loss on money invested by shareholders. Bonus Biogroup's management efficiency ratios could be used to measure how well Bonus Biogroup manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Smadar BarberTsadik | First International Bank | 52 | |
| Shay Basson | Migdal Insurance | 49 | |
| Benjamin Gurevitz | Clal Insurance Enterprises | 54 | |
| Ephraim Senderov | Migdal Insurance | 45 | |
| Dina Navot | Mizrahi Tefahot | ||
| Yoav Manor | Harel Insurance Investments | 62 | |
| Yosef Baruch | Migdal Insurance | 46 | |
| Limor Danesh | Migdal Insurance | 39 | |
| Yoram Naveh | Clal Insurance Enterprises | ||
| Ilana Bar | Migdal Insurance | 49 | |
| Izzy Cohen | Clal Insurance Enterprises | 65 | |
| Shai Kompel | Menora Miv Hld | 58 | |
| Esther Deutsch | Israel Discount Bank | 57 | |
| Ofer Eliahu | Migdal Insurance | 58 | |
| Jacob Sitt | First International Bank | 40 | |
| Smadar BarberTsadik | FIBI Holdings | 52 | |
| Jacob Sitt | FIBI Holdings | 40 | |
| Amir Hessel | Harel Insurance Investments | 50 | |
| Daniel Tsiddon | Bank Leumi Le Israel | 59 | |
| Avner Mendelson | Bank Leumi Le Israel | 48 | |
| Michel Siboni | Harel Insurance Investments | 64 | |
Management Performance
| Return On Equity | -0.55 | |||
| Return On Asset | -0.0636 |
Bonus Biogroup Leadership Team
Elected by the shareholders, the Bonus Biogroup's board of directors comprises two types of representatives: Bonus Biogroup inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bonus. The board's role is to monitor Bonus Biogroup's management team and ensure that shareholders' interests are well served. Bonus Biogroup's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bonus Biogroup's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Rauch, Chairman of the Board, Vice President - Business Development | ||
| Gil Shapira, Director | ||
| Vered Kivity, Head Affairs | ||
| Daniel BenLulu, Director | ||
| Shai Meretzki, CEO and Presidentident, Director | ||
| Yoni CPA, Chief Officer | ||
| Joseph MBA, Ex Chairman | ||
| Avi Slonim, External Director | ||
| Yehonatan Livne, CFO | ||
| Yehuda Reznik, Director | ||
| Rachel Ari, Director | ||
| Batia Avital, Director | ||
| Yosef Rauch, Chairman of the Board, Vice President - Business Development |
Bonus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bonus Biogroup a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.55 | |||
| Return On Asset | -0.0636 | |||
| Current Valuation | 169.66 M | |||
| Shares Outstanding | 1.17 B | |||
| Shares Owned By Insiders | 49.72 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Book | 3.39 X | |||
| EBITDA | (88.03 M) | |||
| Net Income | (90.08 M) | |||
| Cash And Equivalents | 3.6 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bonus Biogroup in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bonus Biogroup's short interest history, or implied volatility extrapolated from Bonus Biogroup options trading.
Pair Trading with Bonus Biogroup
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bonus Biogroup position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bonus Biogroup will appreciate offsetting losses from the drop in the long position's value.Moving together with Bonus Stock
| 0.61 | BIGT | Big Tech 50 | PairCorr |
Moving against Bonus Stock
| 0.59 | NXTG | Nextage Therapeutics | PairCorr |
The ability to find closely correlated positions to Bonus Biogroup could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bonus Biogroup when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bonus Biogroup - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bonus Biogroup to buy it.
The correlation of Bonus Biogroup is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bonus Biogroup moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bonus Biogroup moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bonus Biogroup can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bonus Biogroup. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Bonus Stock analysis
When running Bonus Biogroup's price analysis, check to measure Bonus Biogroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus Biogroup is operating at the current time. Most of Bonus Biogroup's value examination focuses on studying past and present price action to predict the probability of Bonus Biogroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus Biogroup's price. Additionally, you may evaluate how the addition of Bonus Biogroup to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |